Rambam Medical Center
Rambam Medical Center
Haifa, Israel19 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, Lung Injury, Ventilator-Induced Lung Injury, bronchopulmonary dysplasia, lung disorder, respiratory system disorder | Recruiting | Phase 2 / Phase 3 | 2026-10-09 | NCT06897839 | |
| CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, refractory hematologic cancer | Recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT03328078 | |
| Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC) | Neoplasms by Histologic Type, basal cell carcinoma, basal cell neoplasm, carcinoma, epithelial neoplasm, neoplasm | Active, not recruiting | Phase 2 | 2026-09-17 | NCT06422936 | |
| Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration | Geographic Atrophy, age-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-17 | NCT06087458 | |
| Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults | Hypocalcemia, Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, calcium metabolic disease, endocrine system disorder, hypoparathyroidism, metabolic disease, parathyroid gland disorder | Active, not recruiting | Phase 2 | 2026-08-14 | NCT06547151 | |
| Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-08-11 | NCT04790474 | |
| A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET | digestive system neuroendocrine neoplasm | Active, not recruiting | Phase 3 | 2026-07-28 | NCT05050942 | |
| Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, heart failure, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-07-16 | NCT07293923 | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma | Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, carcinoma, epithelial neoplasm, neoplasm, skin disorder, skin neoplasm, squamous cell carcinoma, squamous cell neoplasm | Active, not recruiting | Not applicable | 2026-06-16 | NCT05323253 | |
| Post-Marketing Study to Assess the Safety & Efficacy of RenalGuard® Therapy for Prevention CSA-AKI | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Not applicable | 2026-01-23 | NCT06811805 | |
| Delayed Surveillance Colonoscopy Following Piecemeal EMR | Colon Cancer Prevention; Polyp Colorectal | Not yet recruiting | Not applicable | 2026-01-09 | NCT07328308 | |
| Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, small cell lung carcinoma | Active, not recruiting | Not stated | 2025-10-15 | NCT04056247 | |
| Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, Osteopenia, bone disorder, metabolic disease, musculoskeletal system disorder | Recruiting | Phase 4 | 2025-09-18 | NCT06762730 | |
| Seizure Prediction Using Wearable EEG | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Not stated | 2025-08-26 | NCT06978842 | |
| High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) | High-Risk Neuroblastoma; Patient With Insufficient Response Chemoimmunotherapy | Recruiting | Phase 3 | 2025-06-26 | NCT04221035 | |
| Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF | Acute Decompensated Heart Failure | Recruiting | Not applicable | 2025-05-25 | NCT05759806 | |
| AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not stated | 2025-03-26 | NCT06378632 | |
| Vsling™ I: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart Failure | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 2 | 2025-02-28 | NCT06851949 | |
| Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus | Type1diabetes | Recruiting | Not stated | 2024-10-17 | NCT04834518 |